Novel 99mTc-Labeled Glucose Derivative for Single Photon Emission Computed Tomography: A Promising Tumor Imaging Agent.
Xuran ZhangQing RuanXiaojiang DuanQianqian GanXiaoqing SongSian FangXiao LinJin DuJunbo ZhangPublished in: Molecular pharmaceutics (2018)
In this study, a d-glucosamine derivative with an isonitrile group (CN5DG) was synthesized and it was chosen to coordinate with 99mTc for preparing 99mTc-CN5DG. 99mTc-CN5DG could be readily obtained with high radiochemical purity (>95%) and had great in vitro stability and metabolic stability in urine. The radiotracer demonstrated a positive response to the administration of glucose and insulin in S180 and A549 tumor cells in vitro, suggesting the mechanism of 99mTc-CN5DG into tumor cells was related to glucose transporters. Biodistribution studies in mice bearing A549 xenografts showed 99mTc-CN5DG had a high tumor uptake and high tumor-to-background ratios. SPECT/CT images further supported its ability for tumor imaging. As a cheap, conveniently made and widely available probe, 99mTc-CN5DG would become a potential "working horse" and be a breakthrough in 99mTc-labeled radiopharmaceuticals for tumor detection.
Keyphrases
- lymph node metastasis
- computed tomography
- high resolution
- type diabetes
- pet imaging
- adipose tissue
- magnetic resonance imaging
- squamous cell carcinoma
- mass spectrometry
- deep learning
- metabolic syndrome
- blood pressure
- image quality
- climate change
- skeletal muscle
- photodynamic therapy
- human health
- living cells
- glycemic control
- dual energy
- insulin resistance
- fluorescent probe
- case control